Skip Nav Destination
Article navigation
1 April 2012
Drug Update|
April 01 2012
Efficacy and Safety of Pharmacological Options for Rate Control in Atrial Fibrillation
Katie O’Brien, PharmD;
Katie O’Brien, PharmD
Katie O’Brien is Clinical Pharmacist, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606 (ko’[email protected]). Earnest Alexander is Clinical Manager, Department of Pharmacy Services, and Critical Care Pharmacy Residency Program Director, Tampa General Hospital, Tampa, Florida. Lindsay Patel is Clinical Pharmacist, Tampa General Hospital, Tampa, Florida.
Search for other works by this author on:
Earnest Alexander, PharmD;
Earnest Alexander, PharmD
Katie O’Brien is Clinical Pharmacist, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606 (ko’[email protected]). Earnest Alexander is Clinical Manager, Department of Pharmacy Services, and Critical Care Pharmacy Residency Program Director, Tampa General Hospital, Tampa, Florida. Lindsay Patel is Clinical Pharmacist, Tampa General Hospital, Tampa, Florida.
Search for other works by this author on:
Lindsay Patel, PharmD, BCPS
Lindsay Patel, PharmD, BCPS
Katie O’Brien is Clinical Pharmacist, Tampa General Hospital, 1 Tampa General Circle, Tampa, FL 33606 (ko’[email protected]). Earnest Alexander is Clinical Manager, Department of Pharmacy Services, and Critical Care Pharmacy Residency Program Director, Tampa General Hospital, Tampa, Florida. Lindsay Patel is Clinical Pharmacist, Tampa General Hospital, Tampa, Florida.
Search for other works by this author on:
AACN Adv Crit Care (2012) 23 (2): 120–125.
Citation
Katie O’Brien, Earnest Alexander, Lindsay Patel; Efficacy and Safety of Pharmacological Options for Rate Control in Atrial Fibrillation. AACN Adv Crit Care 1 April 2012; 23 (2): 120–125. doi: https://doi.org/10.4037/NCI.0b013e318242fdd0
Download citation file:
Sign in
Don't already have an account? Register
Short-term Access
Purchase short-term access on a pay-per-article or pay-per-issue basis.
$15 72 - hour single article access $30 7 - day full issue access
.svg?versionId=1461)